Jessica Flanigan discusses the ethics of prescribing cognitive enhancing drugs (Quartz)

Jessica Flanigan, assistant professor of leadership studies and philosophy, politics, economics and law, argues for a broader risk-benefit calculus for prescribing stimulants.

Flanigan states, "...if it’s possible to judge that, on balance, it’s a benefit to take stimulants in those cases, it seems conceivable that the risk-benefit calculus could come out in favor of stimulus for students who face other kinds of cognitive impairments." Read the full interview in Quartz.